Financing, Equity Capital Markets

Adverum Biotechnologies, Inc.

08/20
|
$216.8 Million
Piper Sandler served as bookrunner for Adverum Biotechnologies, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma